Larvol Delta - KANNON5-Andamertinib-With-or-Without-Platinumdoublet-Chemotherapy-Versus-Platinumdoublet-Chemotherapy-in-Patients-With-NSCLC-Harboring-Atypical-EGFR-Mutations

andamertinib (PLB1004) - Avistone Biotech

http://clinicaltrials.gov/ct2/show/NCT07336732

Mar 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next